☰
×
Top 20
Insights
Insight+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
App
Advertisement
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
COVID-19 Vaccine
Sanofi and GSK Report Results of COVID-19 Vaccine in the P-III (VAT08) Trial Against Omicron
June 24, 2022
Pfizer-BioNTech’s COVID-19 Vaccine Receive the US FDA’s EUA for COVID-19 in Children Aged 6 Months through 4 Years of Age
June 21, 2022
Pfizer and BioNTech Seek the US FDA’s EUA for Booster Dose of their COVID-19 Vaccine in Children Aged 5 Through 11 Years
April 27, 2022
Takeda’s Nuvaxovid COVID-19 Vaccine Receives the MHLW Approval for the Treatment of COVID-19
April 19, 2022
Pfizer and BioNTech Seek Approval for Booster Dose of their COVID-19 Vaccine in Children 5 Through 11 Years of Age
April 15, 2022
Moderna Reports Interim Results of COVID-19 Vaccine (mRNA-1273) in P-II/III (KidCOVE) Study for Children Aged 6 Months to Under 6...
March 24, 2022
Load more...
No more records!